title: Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia.
authors: Department of Ophthalmology, University of Malaya Medical Centre, Jalan University, Kuala Lumpur, Malaysia. mohanslayer@gmail.com.
authors: Mohanarasan
authors: M
authors: Ratanam
authors: Department of Ophthalmology, Sultanah Fatimah Hospital, Muar, Johor, Malaysia.
authors: You Siang
authors: YS
authors: Ngim
authors: Department of Ophthalmology, University of Malaya Medical Centre, Jalan University, Kuala Lumpur, Malaysia.
authors: Nurliza
authors: N
authors: Khalidin
authors: Department of Ophthalmology, University of Malaya Medical Centre, Jalan University, Kuala Lumpur, Malaysia.
authors: Visvaraja
authors: V
authors: Subrayan
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D012163:Retinal Detachment / Q000188:drug therapy / Q000209:etiology; D012170:Retinal Vein Occlusion / Q000188:drug therapy / Q000209:etiology; D008258:Waldenstrom Macroglobulinemia / Q000150:complications / Q000188:drug therapy
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab
keywords: B Cells; Waldenström macroglobulinaemia; plasma exchange; vascular endothelial growth factors; venous thrombosis